Suppr超能文献

[外周静脉通路闭塞患者的替代血液透析导管置入通路]

[Alternate hemodialysis catheterization access in patients with occluded peripheral venous access sites].

作者信息

Wacker F K, Lipuma J, Blum A

机构信息

Klinik und Hochschulambulanz für Radiologie und Nuklearmedizin, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin.

出版信息

Rofo. 2005 Aug;177(8):1146-50. doi: 10.1055/s-2005-858363.

Abstract

PURPOSE

The goal of this study was to evaluate translumbar and transhepatic placement of hemodialysis (HD) catheters for patients with occlusion of the veins that are commonly used for hemodialysis access.

METHOD

Over a 12-month period three translumbar and one transhepatic hemodialysis catheters were placed in 4 patients suffering from end-stage renal disease, who had thrombosis of the upper and lower extremity veins as well as the jugular veins. The percutaneous access was performed under fluoroscopic guidance. After successful passage of a guidewire into the right atrium and creation of a subcutaneous tunnel at the skin entry site, all patients received a 14 F double-lumen catheter that was placed with its tip in the right atrium.

RESULTS

Percutaneous translumbar and transhepatic placement of the HD catheters was successful in all patients. No intervention-associated complications were observed. Hemodialysis could be started 1 to 20 hours after initial catheter placement in all patients. During an observation period of 3 to 7 months, 3 patients underwent hemodialysis without any complications. In one patient, an occlusion of an translumbar HD catheter was observed after 5 months. This catheter could be temporarily recanalized using rTPA injection and was then exchanged after 6 months.

CONCLUSION

Transhepatic and translumbar placement of HD catheters is a safe and viable alternative for patients who have exhausted conventional venous access sites.

摘要

目的

本研究的目的是评估对于那些常用于血液透析通路的静脉发生闭塞的患者,经腰和经肝放置血液透析(HD)导管的情况。

方法

在12个月期间,为4例终末期肾病患者放置了3根经腰血液透析导管和1根经肝血液透析导管,这些患者的上肢和下肢静脉以及颈静脉均发生了血栓形成。经皮穿刺在荧光透视引导下进行。在导丝成功进入右心房并在皮肤穿刺部位建立皮下隧道后,所有患者均接受了一根14F双腔导管,其尖端置于右心房。

结果

所有患者经皮经腰和经肝放置HD导管均成功。未观察到与干预相关的并发症。所有患者在首次放置导管后1至20小时即可开始血液透析。在3至7个月的观察期内,3例患者进行血液透析无任何并发症。1例患者在5个月后观察到经腰HD导管闭塞。该导管可通过注射重组组织型纤溶酶原激活剂(rTPA)暂时再通,然后在6个月后更换。

结论

对于那些常规静脉通路部位已用尽的患者,经肝和经腰放置HD导管是一种安全可行的替代方法。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验